Results 151 to 160 of about 345,131 (363)

Febrile seizure in children with COVID-19 during the Omicron wave. [PDF]

open access: yesFront Pediatr, 2023
Xu P, Chen X, Zhou J, Zhou W, Wang L.
europepmc   +1 more source

Evaluation of Demographic and Clinical Characteristics of First Febrile Seizures in Children

open access: yesMajallah-i Dānishgāh-i ’Ulūm-i Pizishkī-i Shahīd Ṣadūqī Yazd, 2009
Introduction: Febrile seizure is the most common problem in pediatric neurology that occur s in 3– 4% of children. The purpose of this study was to evaluate demographic and clinical characteristics of first febrile seizures in children admitted to the ...
F Mir-Naseri   +2 more
doaj  

Evaluation of Vitamin D Level in Children With Febrile Seizure Referred to Amirkola Children's Hospital, Babol. [PDF]

open access: yesGlob Pediatr Health, 2023
Mohammadi M   +6 more
europepmc   +1 more source

Food Safety Practices and Foodborne Illness in Italian Pediatric Oncology and Hematology Centers: A Survey on Behalf of the Infectious Disease Working Group of AIEOP

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Food safety practices are widely recommended for pediatric patients with cancer or undergoing hematopoietic stem cell transplantation (HCT) to mitigate foodborne infectious risks. However, specific measures, such as the neutropenic diet (ND) or low‐microbial diet, lack robust evidence and are inconsistently implemented across ...
Davide Leardini   +28 more
wiley   +1 more source

The Value of Early Postictal EEG in Children with Complex Febrile Seizures [PDF]

open access: bronze, 2000
Joseph Maytal   +3 more
openalex   +1 more source

Nanoparticle Therapeutics in Clinical Perspective: Classification, Marketed Products, and Regulatory Landscape

open access: yesSmall, EarlyView.
This review presents a detailed overview of clinically approved nanoparticle therapeutics, classifying them by type and discussing their unique advantages in drug delivery. It highlights regulatory challenges across global markets and emphasizes the need for adaptive approval pathways.
Nimeet Desai   +5 more
wiley   +1 more source

Preventive treatment for recurrent febrile seizures [PDF]

open access: bronze, 2000
Heikki Rantala, Rita Tarkka, Matti Uhari
openalex   +1 more source

Use of 5% Topical Minoxidil Application for Telogen Effluvium: An Open‐Label Single‐Arm Clinical Trial

open access: yesThe Journal of Dermatology, EarlyView.
ABSTRACT Telogen effluvium (TE) is an acute and diffuse hair loss due to an abnormal increase in telogen hair follicles in response to external or internal factors. Recently, TE attracts global interest as a major cause of hair loss as a sequela of COVID‐19.
Manabu Ohyama   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy